chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shot site soreness; red; itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (shot site soreness), INJECTION SITE ERYTHEMA (red) and INJECTION SITE PRURITUS (itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced INJECTION SITE PAIN (shot site soreness), INJECTION SITE ERYTHEMA (red) and INJECTION SITE PRURITUS (itching). At the time of the report, INJECTION SITE PAIN (shot site soreness) outcome was unknown and INJECTION SITE ERYTHEMA (red) and INJECTION SITE PRURITUS (itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Cough began on 3/17/21 and lasted a month; chills and fever began 3/18 (102.5 on 3/23/21) and lasted 2 weeks.  Took Ibuprofen from 3/18/21 thru 2nd week of April because feeling of chills/fever would occur when I stopped taking it.
AT THE TIME OF PATIENT GETTING HER SECOND VACCINATION; SHE REPORTED HAVING A RED AREA ABOUT 2 INCHES IN DIAMETER AROUND THE INJECTION SITE FOR ABOUT 2-3 WEEKS, AFTERWARDS UNTIL RESOLUTION, SHE DESCRIBED IT AS WARM TO TOUCH, AND FELT IRRITATION WHEN MOVING THE ARM. SHE DENIED ANY BOTHERSOME PAIN ABOUT THE AREA. THE PATIENT REPORTED NOT SEEKING ANY MEDICAL ATTENTION AS THINKING HER IMMUNE SYSTEM WAS DOING ITS JOB.
5 to 10 minutes after receiving 3 injections pt became faint. Glucose level 80. Administered 4 oz fruit juice. VS WNL. Patient fully recovered 10 -15 minutes post administration.
Patient started complaining of headache and chest pain soon after vaccination.  Since then he has been to the Emergency Room 6-7 times for chest pain - workup is consistently negative He has seen two Cardiologists, a Neurologist and has had further workup.  It should be said that I feel it is probably not vaccine related and is likely anxiety related - however patient insists that it is related to the vaccine - he has never felt like this before.
I went to a college basketball game on 01/21/2023. The following Monday, I was coughing through the night. I didn't feel massively sick but could tell things were off. On 01/24/2023, I tested myself for COVID-19 and was positive. I had light flu like symptoms. I called my doctor and did a telehealth appointment and was prescribed Paxlovid on 02/25/2023. My symptoms did not get worse after beginning the Paxlovid.
Woke up in the middle of the night following the shots with chills and 101 fever, severe joint aches and muscle/body aches. Tylenol brought fever down to 100 range but chills persisted for a total of 2 nights and fever stayed above 100 until 72 hours after shots, when it came down to 99 range. Finally in normal range 90 hours after shots received. Muscle/body aches persisted for 72 hours and exhaustion persisted over a week. Could not sit up in bed or get out of bed all day Tuesday and Wednesday after receiving shots Monday.
Headaches, Migranes, Neck pain, Nausea, lose of appatiate, disoreintation.
tingling all over the body and tongue, no SOB or tongue swollen  Benadryl po given   declined tent OBS
Severe splitting headache- Hives all over body resulting in extreme itching and the need for steroid pack.
COVID Arm (left arm injection site) right away after first primary dose; Red left arm from shoulder to forearm, right away after first primary dose; Painful left arm from shoulder to forearm, right away after first primary dose; Scratched a lot, left arm injection site, right away after first primary dose; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (COVID Arm (left arm injection site) right away after first primary dose), VACCINATION SITE ERYTHEMA (Red left arm from shoulder to forearm, right away after first primary dose), VACCINATION SITE PAIN (Painful left arm from shoulder to forearm, right away after first primary dose) and SCRATCH (Scratched a lot, left arm injection site, right away after first primary dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE REACTION (COVID Arm (left arm injection site) right away after first primary dose), VACCINATION SITE ERYTHEMA (Red left arm from shoulder to forearm, right away after first primary dose), VACCINATION SITE PAIN (Painful left arm from shoulder to forearm, right away after first primary dose) and SCRATCH (Scratched a lot, left arm injection site, right away after first primary dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Jan-2021, VACCINATION SITE REACTION (COVID Arm (left arm injection site) right away after first primary dose), VACCINATION SITE ERYTHEMA (Red left arm from shoulder to forearm, right away after first primary dose), VACCINATION SITE PAIN (Painful left arm from shoulder to forearm, right away after first primary dose) and SCRATCH (Scratched a lot, left arm injection site, right away after first primary dose) had resolved.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.  No concomitant medications was provided. It was reported that, all symptoms last for 2 weeks.   This case was linked to MOD-2022-664771, MOD-2022-664782 (Patient Link).
Swelling in left arm lasting from (9/02/2021- present). Burning, aching sensation on back left-side starting (09/15/2021- present).
Ringing in my ears started about the same time that I left the clinic parking lot.  As of writing this at 7:23 am the following morning it has not gone away.
Patient with prior history of Hepatitis (I do not know type). Recieved smallpox vaccination and noted to be progressively jaundiced. Currently diagnosed as possibly having autoimmune hepatitis and/or chronic hepatitis. Patient has been an inpatient at hosptial since 03/03/03.
Received her second dose of Moderna Covid vaccine yesterday (5/23), subsequently this morning (5/24) noted to feel lethargic, dizzy, and had elevated temperature.  She sought medical attention and in the ER was found to have temperature of 104°F, tachycardia, and elevated lactic acid. The patient has had no headache, change in vision, photophobia, neck stiffness, abdominal pain, cough.  There is no report of sick contacts the patient resides with daughter-in-law and son.  She received Rocephin empirically in the emergency room along with 30 mL/kg IV fluid bolus.
After few minutes pt had his vaccines he came back to the clinic with SOB, wheezing, his face and bulbar conjunctivitis was flushed, the lips swelling. Pulse oxymeter read 81%, given EpiPen 0.18ml, oxygen 3 ltrs, after 15 minuts pt was clear lungs and decreased the size of hives.
This report has been received from the nurse reported that VARIVAX (Merck) (lot# H020587, expiration date 13-NOV-2014) and PROQUAD (Merck) (MARRS# 1311USA012185) were through unsupported temperature excursions on 26-JUN-2013, 01-JUL-2013, 22-JUL-2013 thru 31-JUL-2013 and the entire month of August 2013. On 05-SEP-2013 the patient (age and gender not reported) was administered the unsupported VARIVAX (Merck) (dose and route not reported). No adverse effects reported. This is one of several reports received from the same source (MARRS# 1311USA002616, 1312USA003307, 1312USA003308, 1313USA003309, 1312USA003306, 1312USA003310, 1312USA003312, 1312USA003311, 1312USA003314, 1312USA003315, 1312USA003316, 1312USA003317, 1312USA003399, 1312USA003400, 1312USA003401). Additional information has been requested.
A spontaneous report from a 66 year old female pt who, ten days post vax, she experienced puffy and red eyes, which resolved in 3 days. On 7/20/99, the pt received the 2nd dose (1st dose on 6/15/99) and 10 days later re-experienced these same symptoms. The symptoms were treated with Claritin and Benadryl cream around the outer eye. The most recent information reports the symptoms resolved in 3 days.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hyperthyroidism" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 09Jun2022, outcome "unknown", COVID-19 (medically significant) with onset 09Jun2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative, notes: rapid; (09Jun2022) Positive. Therapeutic measures were not taken as a result of covid-19.  Clinical information: The patient had other medication in 2weeks. The patient had no known allergies. The patient had rebound infection- tested positive on 09Jun2022 after previous negative rapid test. Symptoms reoccurred 08Jun2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Blurred vision; Fast heart rate; Tingling; numbness of skin especially limbs and face; Muscle weakness; 2nd dose not taken; Sore arm; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Fast heart rate), PARAESTHESIA (Tingling), HYPOAESTHESIA (numbness of skin especially limbs and face), MUSCULAR WEAKNESS (Muscle weakness) and VISION BLURRED (Blurred vision) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast heart rate) (seriousness criterion hospitalization), PARAESTHESIA (Tingling) (seriousness criterion hospitalization), HYPOAESTHESIA (numbness of skin especially limbs and face) (seriousness criterion hospitalization), MUSCULAR WEAKNESS (Muscle weakness) (seriousness criterion hospitalization), VISION BLURRED (Blurred vision) (seriousness criterion hospitalization), INTENTIONAL PRODUCT USE ISSUE (2nd dose not taken) and MYALGIA (Sore arm). The patient was hospitalized from 08-Jan-2021 to 09-Jan-2021 due to HEART RATE INCREASED, HYPOAESTHESIA, MUSCULAR WEAKNESS and PARAESTHESIA. At the time of the report, HEART RATE INCREASED (Fast heart rate), PARAESTHESIA (Tingling), HYPOAESTHESIA (numbness of skin especially limbs and face), MUSCULAR WEAKNESS (Muscle weakness), VISION BLURRED (Blurred vision), INTENTIONAL PRODUCT USE ISSUE (2nd dose not taken) and MYALGIA (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information, if any, was not provided by the reporter. Treatment information for the events included metoprolol (unknown dose/directions) and acupuncture treatment to get the nerve sensation back.  On 05 Jan 2021, the patient went to an emergency room due to the events. On 08 Jan 2021, the patient went back to the hospital and was admitted. Blood work and a stress test were performed. Results of these tests were not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
big red area over the injection site.; night sweats; arm sore; chills; fever; bodyache; I felt awful; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills) and PYREXIA (fever) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced FEELING ABNORMAL (I felt awful), CHILLS (chills), PYREXIA (fever) and MYALGIA (bodyache). 08-May-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 09-May-2021, the patient experienced NIGHT SWEATS (night sweats). On 10-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red area over the injection site.). At the time of the report, FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills), PYREXIA (fever), MYALGIA (bodyache) and VACCINATION SITE ERYTHEMA (big red area over the injection site.) outcome was unknown. Not Provided          Treatment information was not provided. Concomitant product use was not provided
Headache and hearing difficulty to right side 2 days prior to vaccination. Day of vaccination HA again prior to vaccination; after vaccination at 1:00 AM, other employees started noticing changes to patient's face; at 4:30 AM noticeable right side facial droop and patient sent to the ER for evaluation; other symptom noted on evaluation were right sided facial weakness, abnormal taste to the right side, left sided upper extremity numbness, headache, nausea, not able to move facial muscles on right side of face.
I had Headache;  High sore throat; Fatigue;  Low grade Fever 100.8.  Runny nose; Nausea; Coughing;  and Diarrhea.  I did a tele health 06/01/2022 they prescribed me Paxlovid  for 5 days and basic instruction for COVID-19. I  was also told  ibuprofen  or Tylenol if needed.  I had a rebound  after I finished taking Paxlovid. After 3 days Low grade; runny nose and I was very tired.
Patient describes "twitching" of right eye 1-2 hours of receiveing the flu vaccine. He went to bed early around 8:30pm hoping to see if sleep would help.  "twitching" remains today. he called the Health Center to report the observation. He is in no distress otherwise. Recommended he call his primary  physician. Health department contacted for advice.  Other than report to private MD, no other advice noted.  VAERS report.  Contact with patient at 11am notes no relief from "twitch".
Per pt, left upper arm, swollen, red, hot with radiation to axilla and swollen left axillary nodes. Could not close arm. Given Keflex PO and then IM as worsens. Seen our office 04/01/2003 at 3:15. Left deltoid quarter size area of induration and tenderness only. All of them Sx resolved.
Fainted, lost hearing 20-30 minutes after vaccination. Fully recovered 15-20 minutes after fainting.
Nausea; Body ache; Flu Like Symptoms; Upset Stomach; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 4 months after receiving Shingrix, the patient experienced nausea, general body pain, influenza-like symptoms and upset stomach. On an unknown date, the outcome of the nausea, general body pain, influenza-like symptoms and upset stomach were recovered/resolved.   It was unknown if the reporter considered the nausea, general body pain, influenza-like symptoms and upset stomach to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix 3 to 4 months ago. After vaccination, the patient experienced nausea, body aches, flu like symptoms and upset stomach that lasted for 4 days. No further details were provided The reporter did not consent to follow up.
VACCINE WAS DRAWN UP DAY BEFORE AND WAS GIVEN AT THE 15 HOUR MARK, PER MODERNA REP CLIENT WAS TO BE CALLED TO SEE IF ANY ADVERSE REACTIONS.  CLIENT DENIES ANY ADVERSE REACTIONS.  NO NEED TO REVACCINATE
Sickness; nauseated; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness), NAUSEA (nauseated) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2022, the patient experienced ILLNESS (Sickness), NAUSEA (nauseated) and HEADACHE (Headache). In March 2022, ILLNESS (Sickness), NAUSEA (nauseated) and HEADACHE (Headache) had resolved.            No concomitant medication were provided.  No treatment medication were provided.
Information has been received from certified medical assistant regarding unspecified patients of unknown age and gender. On unknown dates the patients received improperly stored PNEUMOVAX23 (doses, lot #s, Expiration dates and routes not reported), exposed to 22 F hours. No adverse effects were reported. It was unknown if the patients sought medical attention. Additional information has been requested.
Chief Complaint: COVID-positive/generalized weakness/shortness of breath Additional Medical History:  Patient is an 85-year-old male with a history of coronary artery disease with prior MI, congestive heart failure, atrial fibrillation, hypertension, COPD (normally requires 4 L of oxygen 24 hours a day), prior stroke, seizures and anxiety.  Patient tested positive for COVID 9 days ago.  He tested positive after other family members tested positive and he developed some upper respiratory type symptoms.  I saw this patient 6 days ago in the emergency room for some generalized fatigue and worsening cough with shortness of breath.  He had a full work-up at that time and was on Paxlovid.  He felt better and was ultimately discharged home on steroids.  Patient states he did really well for couple of days however over the last 3 to 4 days has continued to become weaker and weaker and feel more short of breath with a worsening cough.  Patient states he is having a very difficult time getting around his house and normally would be able to do so without any difficulty.  He lives at home with his wife.  He has also required increased oxygen at 6 L up from his normal 4 L.  Patient states every time he attempts to get up or walk around his oxygen saturations fall into the high 80s.  He denies any associated chest pain.  Denies fever or chills.  His main complaint at this time is weakness.
Information has been received from a female patient of unknown age referring to herself. The patient became pregnant with last menstrual period (LMP) of 05-JUL-2015 and expected delivery of date (EDD) of 10-APR-2016. On 29-JAN-2016 (pregnancy at 29 weeks and 4 days), the patient was injected in error with an HPV vaccine (route, dose and lot# were unknown) in the left arm instead of an TDAP vaccine by a nurse in her physician's office (wrong drug administered and exposure during pregnancy). The patient could not identify the specific HPV vaccine. GARDASIL or GARDASIL 9 could not be ruled out (product origin unknown). No adverse effect was reported. The pregnancy outcome was pending. Additional information is not expected as the physician didn't like to be contacted.
Experienced an adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Experienced an adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Experienced an adverse reaction). At the time of the report, ADVERSE DRUG REACTION (Experienced an adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Injection site redness, swelling, and pain. Treated with Ibuprofen. Still occurring.
Patient describes respiratory difficulty at 3:30pm. Patient had a headache, took ADVIL & used an albuterol inhaler.
Following morning after getting vaccine woke up with chills headache and a fever of 100.8. I spoke with my PCP and she advised that I take some ibuprofen.
On 7/15/22 patient received Moderna COVID-19, age 6mo-5yr, 0.25ml dose of vaccine. NDC #80777-279-05, Lot # AS1412B, exp. 2/10/23, in left thigh. Patient tolerated fine, no adverse reactions. On 8/10/22 patient received incorrect 2nd COVID-19 vaccine, Pfizer-BioNTech, NDC #59267-0078-1, Lot # FL007, exp. 8/30/22, in left thigh. Patient tolerated in clinic and was monitored for 20min. post immunization. Parents informed of error. Both Moderna (case ID # MOD22-020733) and Pfizer (Case # 00733060) called for further information. CDC "Vaccine administration errors and deviations" guidelines provided and recommended. Parents notified by MD.
Break through Covid 19 case on July 21, 2022, symptoms were sneezing, runny nose, cough, mild fatigue. Had a video appointment with  my doctor 8am July 22nd and was prescribed Paxlovid. Took first dose at 5PM on July 22 and 2nd at 1AM on July 23, have continued twice a day, last dose 9PM July 26. Symptoms have improved.
Pt got the 2nd shot earlier that he supposed to. He got the first shot at 6/10/2021, and we gave the 2nd dose on 6/21/2021, only 11 days in between.  No adverse effects reported from patient
Pt came in for H1N1 shot. She forewarned us that time she got a shot of any kind she passes out. About 1 min after her vaccination she passed out. Pt was put in supine position and monitored. Her BP and HR were taken every 15 min and then reported below. Pt recovered quickly after about 15 min. No report and no other allergic reactions such as rash hives and difficulty breathing was reported.
Vaccination administered on 10/4/19, pt was in pain and went to MD's office on 10/7/19. The doctor believes flu shot given high enough on the arm that it penetrated into the bursa sac in the shoulder and is causing inflammation, pain and fever. Patient had MRI and physical therapy.